Access to new medicines in the English NHS

A briefing to describe the process

Source – The King’s Fund

All health systems must find ways to ration limited resources. The question is whether they do so with their eyes closed or with their eyes open. In 2018/19, the English NHS spent almost £19 billion on drugs, almost 15 per cent of total public spending on health. Should the NHS increase drugs spending to pay for the latest drugs for hepatitis or cancer, drugs that might prolong life for some patients but cost tens or even hundreds of thousands of pounds per course of treatment? Or should it spend the money in other areas, for example, ensuring that people can see a GP when they need one, ensuring that vulnerable people get basic treatment for long term-conditions or tackling health inequalities? How health systems make these decisions determines, in large part, their effectiveness. The choices determine the quality of people’s lives and, in some cases, who lives or dies.

To find out more and understand the process click here.